Andrea Kerkhoff

1.7k total citations
33 papers, 578 citations indexed

About

Andrea Kerkhoff is a scholar working on Oncology, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Andrea Kerkhoff has authored 33 papers receiving a total of 578 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 11 papers in Pathology and Forensic Medicine and 9 papers in Hematology. Recurrent topics in Andrea Kerkhoff's work include Lymphoma Diagnosis and Treatment (9 papers), Lung Cancer Treatments and Mutations (5 papers) and Acute Myeloid Leukemia Research (5 papers). Andrea Kerkhoff is often cited by papers focused on Lymphoma Diagnosis and Treatment (9 papers), Lung Cancer Treatments and Mutations (5 papers) and Acute Myeloid Leukemia Research (5 papers). Andrea Kerkhoff collaborates with scholars based in Germany, Switzerland and United States. Andrea Kerkhoff's co-authors include Wolfgang E. Berdel, Christoph Schliemann, Arik Bernard Schulze, Peter Borchmann, Bastian von Tresckow, Michael Fuchs, Paul J. Bröckelmann, Andreas Engert, L. H. Schmidt and Michael Möhr and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Andrea Kerkhoff

30 papers receiving 572 citations

Peers

Countries citing papers authored by Andrea Kerkhoff

Since Specialization

Citations

This map shows the geographic impact of Andrea Kerkhoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Kerkhoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Kerkhoff more than expected).

Fields of papers citing papers by Andrea Kerkhoff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Kerkhoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Kerkhoff. The network helps show where Andrea Kerkhoff may publish in the future.

Co-authorship network of co-authors of Andrea Kerkhoff

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Kerkhoff. A scholar is included among the top collaborators of Andrea Kerkhoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Kerkhoff. Andrea Kerkhoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Outcomes of pirtobrutinib for relapsed/refractory mantle cell lymphoma in compassionate use program in Europe 2024 ·Cancer Medicine ·(unknown), Gerald Wulf, (unknown), Ulrike Bacher, Mathias Rummel, (unknown), Andrea Kerkhoff, (unknown), Thomas Melchardt, Thomas Pabst, Georg Lenz, Evgenii Shumilov	1
2	Chimeric antigen receptor‐T cell therapy shows similar efficacy and toxicity in patients with diffuse large B‐cell lymphoma aged 70 and older compared to younger patients: A multicenter cohort study 2024 ·HemaSphere ·(unknown), Evgenii Shumilov, (unknown), (unknown), Andrea Kerkhoff, (unknown), Christian Reicherts, (unknown), (unknown), Michèle J. Hoffmann, Urban Novak, Michael Daskalakis, Norbert Schmitz, Matthias Stelljes, Gerald Wulf, Ulrike Bacher, Georg Lenz, Thomas Pabst	16
3	1300P Treatment and clinical outcome in recurrent/refractory locally advanced NSCLC following chemoradiotherapy and consolidative durvalumab 2023 ·Annals of Oncology ·Georg Evers, (unknown), Daniel C. Christoph, Wolfgang M. Brueckl, Marcel Wiesweg, (unknown), (unknown), (unknown), (unknown), (unknown), Wolfgang Schütte, Petra Hoffknecht, Andrea Kerkhoff, Michael Möhr, Georg Lenz, Nikolaj Frost, Tobias R. Overbeck, Martin Sebastian, Annalen Bleckmann	0
4	Complete Metabolic Response to Combined Immune Checkpoint Inhibition after Progression of Metastatic Colorectal Cancer on Pembrolizumab: A Case Report 2023 ·International Journal of Molecular Sciences ·(unknown), Klaus Wethmar, Jan‐Henrik Mikesch, Andrea Kerkhoff, Kerstin Menck, Georg Lenz, Hans‐Ulrich Schildhaus, (unknown), (unknown), Andreas Pascher, (unknown), Eva Wardelmann, Annalen Bleckmann	5
5	Long-Term Survival of Patients with Mantle Cell Lymphoma after Total Body Irradiation, High-Dose Chemotherapy and Stem Cell Transplantation: A Monocenter Study 2023 ·Cancers ·(unknown), (unknown), Andrea Kerkhoff, Georg Lenz, Matthias Stelljes, Hans Theodor Eich, Gabriele Reinartz	4
6	Efficacy of COVID-19 Booster Vaccines in Patients with Hematologic Malignancies: Experiences in a Real-World Scenario 2022 ·Cancers ·(unknown), (unknown), Ulrike Bacher, Cyrus Khandanpour, (unknown), (unknown), (unknown), Phil‐Robin Tepasse, (unknown), (unknown), Rolf M. Mesters, (unknown), (unknown), Andrea Kerkhoff, Christoph Schliemann, (unknown), Nicole Schmidt, Georg Lenz, Annalen Bleckmann, Evgenii Shumilov	4
7	Diagnostic, Clinical and Post-SARS-CoV-2 Scenarios in Cancer Patients with SARS-CoV-2: Retrospective Analysis in Three German Cancer Centers 2021 ·Cancers ·Evgenii Shumilov, Petra Hoffknecht, Raphael Koch, Rudolf Peceny, (unknown), Nicole Schmidt, (unknown), Ulrike Bacher, Simone Scheithauer, Lorenz Trümper, Georg Lenz, Andrea Kerkhoff, Annalen Bleckmann	2
8	Long-term survival and polyclonal immunoglobulin reconstitution after allogeneic stem cell transplantation in multiple myeloma 2020 ·Annals of Hematology ·(unknown), Eva Eßeling, Ramona Wullenkord, Cyrus Khandanpour, Julia Reusch, Jan‐Henrik Mikesch, Christian Reicherts, Andrea Kerkhoff, Christoph Schliemann, Torsten Keßler, Rolf M. Mesters, Wolfgang E. Berdel, Georg Lenz, Matthias Stelljes	4
9	Chronic Hepatitis E Virus Infection during Lymphoplasmacytic Lymphoma and Ibrutinib Treatment 2019 ·Pathogens ·Bernhard Schlevogt, Volker Kinast, Julia Reusch, Andrea Kerkhoff, Dimas Praditya, Daniel Tödt, Hartmut Schmidt, Eike Steinmann, Patrick Behrendt	7
10	Adjuvant chemotherapy—Radiotherapy—Chemotherapy sandwich protocol in resectable soft tissue sarcoma: An updated single-center analysis of 104 cases 2018 ·PLoS ONE ·Christoph Schliemann, Andrea Kerkhoff, (unknown), (unknown), Jendrik Hardes, Arne Streitbürger, Dimosthenis Andreou, Georg Gosheger, (unknown), Eva Wardelmann, Wolfgang Hartmann, Rolf M. Mesters, Georg Lenz, Normann Willich, Jan Kříž, Hans Theodor Eich, Wolfgang E. Berdel, Torsten Keßler	6
11	Exacerbation of mycosis fungoides leading to the diagnosis of chronic myelomonocytic leukemia 2018 ·JAAD Case Reports ·Rose K. C. Moritz, Dieter Metze, (unknown), Andrea Kerkhoff, Wolfgang E. Berdel, Carsten Weishaupt	0
12	Gemcitabine combined with the monoclonal antibody nimotuzumab is an active first-line regimen inKRAS wildtype patients with locally advanced or metastatic pancreatic cancer: a multicenter, randomized phase IIb study 2017 ·Annals of Oncology ·Beate Schultheis, Dirk Reuter, M. Ebert, Jens T. Siveke, Andrea Kerkhoff, Wolfgang E. Berdel, Ralf‐Dieter Hofheinz, Dirk Behringer, Wolfgang E. Schmidt, Erdem Göker, Sara De Dosso, Michael Kneba, Şuayib Yalçın, Friedrich Overkamp, Frank Schlegel, (unknown), Robert Rohrberg, (unknown), Michael Bulitta, Dirk Strumberg	97
13	Metastatic triple-negative breast cancer patient with TP53 tumor mutation experienced 11 months progression-free survival on bortezomib monotherapy without adverse events after ending standard treatments with grade 3 adverse events 2017 ·Molecular Case Studies ·Tobias Meißner, Adam Mark, Casey Williams, Wolfgang E. Berdel, Stephanie A. Wiebe, Andrea Kerkhoff, Eva Wardelmann, Timo Gaiser, Carsten Müller‐Tidow, Philip Rosenstiel, Norbert Arnold, Brian Leyland‐Jones, André Franke, Martin Stanulla, Michael Förster	12
14	Late Relapse of Classical Hodgkin Lymphoma: An Analysis of the German Hodgkin Study Group HD7 to HD12 Trials 2017 ·Journal of Clinical Oncology ·Paul J. Bröckelmann, Helen Goergen, (unknown), Bastian von Tresckow, Alden A. Moccia, Jana Marková, Julia Meißner, Andrea Kerkhoff, Wolf‐Dieter Ludwig, Michael Fuchs, Peter Borchmann, Andreas Engert	27
15	Progressive Multifocal Leukoencephalopathy after Ibrutinib Therapy for Chronic Lymphocytic Leukemia 2016 ·Cancer Research and Treatment ·Mathias Lutz, Arik Bernard Schulze, (unknown), (unknown), Tarek Zoubi, Oliver Grauer, Torsten Keßler, Andrea Kerkhoff, Georg Lenz, Wolfgang E. Berdel	21
16	Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trials 2016 ·Blood ·Boris Böll, Helen Goergen, Karolin Behringer, Paul J. Bröckelmann, Felicitas Hitz, Andrea Kerkhoff, Richard Greil, Bastian von Tresckow, Dennis A. Eichenauer, (unknown), Sven Borchmann, Michael Fuchs, Volker Diehl, Andreas Engert, Peter Borchmann	65
17	Phase II, randomized, double-blind placebo-controlled trial of nimotuzumab plus gemcitabine compared with gemcitabine alone in patients (pts) with advanced pancreatic cancer (PC). 2013 ·Journal of Clinical Oncology ·Dirk Strumberg, Beate Schultheis, Matthias Ebert, Andrea Kerkhoff, Ralf‐Dieter Hofheinz, Dirk Behringer, Wolfgang E. Schmidt, Erdem Göker, Sara De Dosso, Michael Kneba, Şuayib Yalçın, Friedrich Overkamp, Frank Schlegel, (unknown), Robert Rohrberg, T. Steinmetz, Dirk Reuter, F. Bach	13
18	Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia 1998 ·Cancer ·Wolfgang Kern, Gerhard Behre, (unknown), Andrea Kerkhoff, (unknown), Hartmut Eimermacher, (unknown), Bernhard Wörmann, Thomas Büchner, Wolfgang Hiddemann	13
19	Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia 1998 ·Cancer ·(unknown), Wolfgang Kern, Gerhard Behre, (unknown), Andrea Kerkhoff, (unknown), Hartmut Eimermacher, (unknown), (unknown), (unknown), Wolfgang Hiddemann	46
20	Granulocyte colony-stimulating factor shortens duration of critical neutropenia and prolongs disease-free survival after sequential high-dose cytosine arabinoside and mitoxantrone (S-HAM) salvage therapy for refractory and relapsed acute myeloid leukemia 1998 ·Annals of Hematology ·Wolfgang Kern, Carlo Aul, Georg Maschmeyer, R. Kuse, Andrea Kerkhoff, (unknown), Hartmut Eimermacher, (unknown), Bernhard Wörmann, Thomas Büchner, Wolfgang Hiddemann	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact